Industry context
Phibro Animal Health [PAHC]
Pivot Data
Pivot Statistics
| Metric | Average | Median | Std Dev |
|---|---|---|---|
| Gain % | 13.64% | 13.64% | 3.13% |
| Loss % | -51.25% | -51.25% | 0.00% |
| Duration | 12.0d | 7d | 13.2d |
| Total Pivots Found | 4 |
| Gain/Loss Legs | 3 (2 Gain / 1 Loss) |
| Last Pivot | Top @ $33.04 on 2026-06-04 |
| Change since Last Pivot | $-2.51 (-7.60%) |
Next Pivot Prediction Last: $31.81
| Predicted Next Type | Bottom |
| Predicted Price (Avg) | $16.11 |
| Predicted Price (Median) | $16.11 |
| Predicted Price Range (~68%) | $16.11 - $16.11 |
| Change to Avg Target | $-15.70 (-49.36%) |
| Predicted Date (Avg) | 2026-06-16 |
| Predicted Date Range (~68%) | 2026-06-02 - 2026-06-29 |
| Basis | Based on 1 historical losses (Avg: -51.25%, Median: -51.25%, StdDev of Abs: 0.00%) and duration (Avg: 12.0 days, StdDev: 13.2 days) |
| Note | Ranges assume ~normal distribution & historical patterns repeat. Use with caution. |
Moderate loss for Phibro Animal Health on Tuesday.
Phibro Animal Health (PAHC) stock price suffered a considerable decline on Tuesday after the stock fell $-0.540 (-1.74%) from the previous session on normal volume. The stock slightly underperformed the market, lagging slightly behind the NASDAQ's 0.22% rise. Yesterday's trading volume was 198 239 shares, worth about $6.05M. This represents 51 900 shares less than the day before. Volume was below the 10-day average of 263 753 shares.
Phibro Animal Health signals
There is no conclusive signals given from RSI. The price is below both moving averages, and the short-term average is below the long-term average, confirming a sustained down-trend. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (-33.3%), medium- (-33.3%), and long-term (-33.3%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.
Phibro Animal Health Support & Resistance Levels
The stock is trading above the closest support level at $29.90. approximately $0.630 (2.06%) away. This suggests it is currently acting as a floor, approaching it.The sup dis das support s129.9 -
Phibro Animal Health Evaluation
- Short score: -2.86
- Medium score: -3.38
- Long score: -3.06
Ownership flow
GetAGraph InsiderPower
Relationship map
Correlation snapshot
Positioning pressure
Short interest pressure
Short positioning does not currently stand out as a dominant risk factor.
Updated 2026-05-29Income profile
Dividend profile
Yearly history
| Year | Dividend | Yield |
|---|---|---|
| - | $0.240 | 0.64% |
| - | $0.480 | 2.32% |
| - | $0.480 | 4.06% |
| - | $0.480 | 3.51% |
| - | $0.480 | 2.30% |
| - | $0.480 | 2.44% |
Recent payments
| Date | Dividend | Payment |
|---|---|---|
| 2026-06-03 | $0.120 | 2026-06-24 |
| 2026-03-04 | $0.120 | 2026-03-25 |
| 2025-11-26 | $0.120 | 2025-12-17 |
| 2025-09-03 | $0.120 | 2025-09-24 |
| 2025-06-04 | $0.120 | 2025-06-25 |
Earnings quality
Earnings history
| Period | Date | Actual EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q1/2026 | 2025-11-04 | $0.650 | - | - | 363.89M |
| Q4/2025 | 2025-08-27 | - | $0.520 | - | - |
| Q3/2025 | 2025-05-07 | $0.630 | $0.520 | 21.15% | 347.83M |
| Q2/2025 | 2025-02-05 | $0.540 | $0.400 | 35.00% | 309.26M |
| Q1/2025 | 2024-11-07 | $0.350 | $0.250 | 40.00% | 260.43M |
| Q4/2024 | 2024-08-28 | $0.410 | $0.340 | 20.59% | 273.16M |
| Q3/2024 | 2024-05-08 | $0.310 | $0.290 | 6.90% | 263.22M |
| Q2/2024 | 2024-02-07 | $0.330 | $0.270 | 22.22% | 249.94M |
Analyst view
Analyst targets
News flow
Latest company news
Market coverage
zacks.com PAHC vs. SYK: Which Stock Is the Better Value Option? Jun 22, 2026 zacks.com What Makes Phibro (PAHC) a New Buy Stock Jun 17, 2026 fool.com Is Beaten-Down Phibro Animal Health Stock a Buy Following an Insider Purchase of 10,000 Shares? Jun 13, 2026 zacks.com PAHC vs. SYK: Which Stock Should Value Investors Buy Now? Jun 3, 2026Company releases
Company context
Company profile
Phibro Animal Health Corporation operates as a global entity focused on the research production and supply of a wide array of animal health and mineral nutrition solutions While serving a global clientele its primary market for livestock products is the United States The companys operations are divided into three main business segments Animal Health Mineral Nutrition and Performance Products Phibro develops manufactures and markets products tailored for various foodproducing animals including poultry swine beef and dairy cattle and aquaculture Its Animal Health offerings encompass a broad range of pharmaceutical and biological products These include antimicrobials both chemical and biological agents designed to prevent and treat bacterial ailments anticoccidials primarily used to control and prevent coccidiosis in poultry and cattle anthelmintics for combating parasitic intestinal worm infestations and specific antibloat treatments for cattle grazing on legume or wheat pastures Additionally the company provides specialized nutritional supplements engineered to enhance animal health and performance alongside vaccines predominantly for the poultry and swine industries to protect against diseases The Mineral Nutrition segment focuses on the creation and distribution of various trace mineral formulations and concentrates featuring elements such as zinc manganese copper iron and other vital compounds Furthermore under its Performance Products segment Phibro supplies an assortment of specialty ingredients that find application in diverse industries including personal care industrial chemicals and chemical catalysts Phibros animal health and mineral nutrition products reach customers through a multichannel distribution network including its own local sales offices direct sales to integrated poultry swine and cattle operations and through commercial animal feed producers wholesalers and distributors The company boasts an extensive international presence conducting business across the United States Latin America Canada Europe the Middle East Africa and the Asia Pacific region Initially known as Philipp Brothers Chemicals Inc the company adopted the name Phibro Animal Health Corporation in July 2003 It was officially incorporated in 2014 and maintains its corporate headquarters in Teaneck New Jersey
Navigation